|
|
Volumn 118, Issue 3, 2008, Pages 88-89
|
|
2007 Focused update of the ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CLOPIDOGREL;
CYCLOOXYGENASE 2 INHIBITOR;
ENOXAPARIN;
FIBRINOGEN RECEPTOR ANTAGONIST;
FONDAPARINUX;
HEPARIN;
HIRULOG;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
MORPHINE;
NONSTEROID ANTIINFLAMMATORY AGENT;
STREPTOKINASE;
THIENOPYRIDINE DERIVATIVE;
ADD ON THERAPY;
ANALGESIA;
ANGIOCARDIOGRAPHY;
CLINICAL FEATURE;
CORONARY ARTERY DISEASE;
DRUG CONTRAINDICATION;
DRUG INDICATION;
EDITORIAL;
FIBRINOLYTIC THERAPY;
HEART INFARCTION;
HEART MUSCLE REPERFUSION;
HUMAN;
INFLUENZA VACCINATION;
LOADING DRUG DOSE;
MEDICAL SOCIETY;
PERCUTANEOUS CORONARY INTERVENTION;
PHYSICAL ACTIVITY;
PRACTICE GUIDELINE;
ST SEGMENT ELEVATION;
VASCULAR DISEASE;
|
|
EID: 41849122339
PISSN: 00323772
EISSN: None
Source Type: Journal
DOI: 10.20452/pamw.316 Document Type: Editorial |
|
Times cited : (1)
|
|
References (2)
|
